Lecture 29 Flashcards

check on learning

1
Q

multi hit hypothesis

clearly defined changes in cellular appearance occurs with neoplastic transformation

A

cell changes in carcinogenesis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what are the two major classes of tumor antigens?

A

tumor associated antigens

tumor specific antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Carcinoembryonic Ag (CEA)
Alpha fetoprotein (AFP)
CD20 and prostate specific Ag (PSA)
VEGF and MUC-1

name this antigen

A

Tumor associated antigens (TAA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

these are abnormal molecules that include mutated self molecules and foreign molecules

A

tumor specific antigens (TSA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

how are tumor antigens expressed?

A

TSA and TAA
markers that indicate cell physiology is alterd
can be cell associated or secreted (altered self cell and function of other cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the stages in tumor progression?

A

dysplasia
invasion
angiogenesis
metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what are the three phases of the Cancer Immunoediting?

A

elimination or immunosurveillance

equilibrium

escape

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

these are the key players in tumor microenvironment?

discussed under elimination or immunosurveillance

A

NK, macs, CD8, cytolytic mechanisms like Fas/FasL, perforin/granzyme, IL-12, IFN-gamma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is neoplastic growth equal to?

A

expression of new Ag and DAMPs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

failure of elimination or immunosurveillance is equal to?

A

survival of tumor cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what are the key players in equilibrium, adaptive response?

A

CD8 CTL, CD4 Th1, IFN-gamma, IL-12, cytotoxic mechanisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the two examples of equilibrium?

A

immunoediting and cancer editing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how does escape occur, what two mechanisms?

A

immune evasion and immune suppression

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what are the major mechanisms of tumor immunoevasion?

A
reducing MHC class I
altering or turning off expression of immunogenic Ags
shedding Ags
masking Ags
outpacing Ags (T cell exhaustion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what are the major mechanisms of tumor immunosuppression?

A
produce immunosuppressive cytokines
induce dysfunctional/tolerogenic DCs
Differentiate MDSC
Activate/recruit Treg cells
Express FasL
Express CTLA4 and PD1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what are the advantages of immunotherapy?

A

specificity target
limit therapy
generate memory immune responses

17
Q

antibody and t cell based therapies are what types of immunotherapies?

A

passive immunotherapies

18
Q

DC based therapies, tumor specific vaccines, cytokine therapy, and inhibitive immunosuppressive is what type of immunotherapy?

A

active immunotherapies

19
Q

what is the goal of immunotherapy? how?

A

increase anti tumor response and inhibit immunosuppression

more targeted therapy
adoptive cell transfer
immunostimulation
changing the immune bias

20
Q

what is the role for passive antibody immunotherapy?

A

targeted delivery of radio or chemotherapeutic agent
depletion of immunosuppressive cell subsets
receptor blockade
protein neutralization

21
Q

what is the role of Tcell based immunotherapy?

A

in vivo t cell proliferation leading to protection and memory response

t cells isolated

recombinant or can be engineered (recombinant TCR and chimeric Ag receptor (CAR))

22
Q

what is unique about the recombinant Chimeric Antigen Receptor (CAR)?

A

Fab fragment provides specificity

tail of CD3 provides activation

23
Q

what is the role/advantage of DC based immunotherapies?

A

deliver tumor Ag in a context that increases immunogenicity

Drive DC differentiation
Increase MHC and CD80/86 expression
create optimal cytokine environment
deliver most immunogenic Ag

24
Q

what is the goal of DC-based immunotherapies?

A

facilitate DC maturation and Ag processing to generate a DC that can rapidly and efficiently activate CD8 CTL

25
Q

what are the counterstrategies for Treg activity?

A

deplete Treg cells
neutralize IL-10, TGF-beta, IDO
anti PD-1 or anti CTLA4 treatment

26
Q

how do the immunotherapies work?

A

increasing innate immunity
increasing T cell and NK cell activation
changing the tumor environment via immunosuppression cells
actively inducing tumor specific immunity
broader combinations of the above